COMMUNIQUÉS West-GlobeNewswire

MediPharm Labs Assembles Globally Renowned Experts to Form Scientific Advisory Committee

08/04/2019 - 13:59

TORONTO, April 08, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQB: MLCPF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, [...]

Oncology Venture invites to a webcast April 8 at 16:30

08/04/2019 - 13:49

Investor News Following the presentation of Oncology Venture’s prospectus as part of the rights issue announced on Friday, April 5, the company invites to a webcast. At the webcast, Oncology Venture’s CEO Peter Buhl [...]

Melinta Therapeutics Announces Multiple Presentations at the 29th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)

08/04/2019 - 13:30

~ Presentations and Posters Highlight New Data from Antibiotics Portfolio ~ MORRISTOWN, N.J., April 08, 2019 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company focused on the [...]

VitalHub Announces Licensing of Patient Flow Solution to Leading Middle East Hospital

08/04/2019 - 13:30

TORONTO, April 08, 2019 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) is pleased to announce that it has licensed its MCAP patient flow software solution to Hamad Medical Corporation (“HMC [...]

IMMUNOTHERAPY COMPANY ENLIVEX THERAPEUTICS COMPLETES PREVIOUSLY ANNOUNCED FINANCING PRICED AT $12.25 PER SHARE, RAISING A TOTAL OF APPROXIMATELY $8.4 MILLION

08/04/2019 - 13:30

Nes Ziona, Israel, April 08, 2019 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV), a clinical-stage immunotherapy company, today announced the final closing of a private placement financing of ordinary [...]

Translate Bio Appoints Richard Wooster as Chief Scientific Officer

08/04/2019 - 13:30

-- Appointment strengthens scientific leadership team and highlights the Company’s commitment to innovative mRNA research and development -- LEXINGTON, Mass., April 08, 2019 (GLOBE NEWSWIRE) -- Translate Bio, Inc. ( [...]

Nephros Announces Preliminary Financial Results for First Quarter 2019

08/04/2019 - 13:30

Anticipates $1.7 Million Revenue; Year-over-Year Growth Exceeds 75% SOUTH ORANGE, NJ, April 08, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device and commercial [...]

Todos and Amarantus Announce Completion of LymPro PET 1 Study by Leipzig University for Alzheimer’s Blood Diagnostic LymPro Test 2.0

08/04/2019 - 13:30

REHOVOT, Israel and NEW YORK, April 08, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro diagnostics company focused on the development of blood tests for the early detection of [...]

American Cannabis Market Fueled By Positive Legislation

08/04/2019 - 13:30

SEATTLE, April 08, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry announces publication of an [...]

Clearside Biomedical Appoints Dr. George Lasezkay as Interim CEO

08/04/2019 - 13:05

ALPHARETTA, Ga., April 08, 2019 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye [...]

Trillium Therapeutics to Present at Investor Conferences in April

08/04/2019 - 13:00

TORONTO, April 08, 2019 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, announced today that the [...]

Kymab Appoints Pharmaceutical Veteran Simon Sturge as Chief Executive Officer

08/04/2019 - 13:00

Kymab Appoints Pharmaceutical Veteran Simon Sturge as Chief Executive Officer Cambridge, UK; April 8, 2019 : Kymab, a clinical-stage biopharmaceutical company developing antibody-based therapeutics, today announced the [...]

Histogenics and Ocugen Enter into Definitive Merger Agreement to Create Nasdaq-Listed Clinical-Stage Company Developing Novel Ocular Gene Therapies and Biotherapeutics

08/04/2019 - 13:00

— Conference call to be held today at 8:30 a.m. Eastern Time — BOSTON, Mass. and MALVERN, Penn., April 08, 2019 (GLOBE NEWSWIRE) -- Histogenics Corporation (Nasdaq: HSGX) and Ocugen, Inc., a privately held clinical- [...]

Evolus Announces Publication of Largest Aesthetic Head-to-Head Pivotal Trial Comparing Jeuveau™ and BOTOX® in Aesthetic Surgery Journal

08/04/2019 - 13:00

Primary Endpoint of Non-Inferiority Achieved with Responder Rates* of 87.2% for Jeuveau™, 82.8% for BOTOX ® and 4.2% for Placebo at Day 30 Secondary and Exploratory Analyses Unveil Additional Information about Jeuveau™ [...]

Neon Therapeutics Announces Completion of Enrollment in Phase 1b NT-002 Clinical Trial of NEO-PV-01 in Metastatic Non-Small Cell Lung Cancer

08/04/2019 - 13:00

First Clinical Trial to Evaluate the Potential of the Personal Neoantigen Vaccine NEO-PV-01 in Combination with Standard of Care in First-Line Metastatic NSCLC Treatment Setting CAMBRIDGE, Mass., April 08, 2019 (GLOBE [...]

Inspire Medical Systems, Inc. Announces Three New Positive Coverage Policies Issued by Blue Cross Blue Shield Plans

08/04/2019 - 13:00

MINNEAPOLIS, April 08, 2019 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive [...]

Emerald Health Therapeutics Receives Standard Processing License for Verdélite Facility in Quebec

08/04/2019 - 13:00

New license gives Verdélite ability to extract and process cannabis for the development and manufacture of next-generation cannabis products VANCOUVER, British Columbia, April 08, 2019 (GLOBE NEWSWIRE) -- Emerald Health [...]

AGTC Announces Reaching Enrollment Milestones in Phase 1/2 Clinical Trials

08/04/2019 - 13:00

GAINESVILLE, Fla., and CAMBRIDGE, Mass., April 08, 2019 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus ( [...]

Auxly Announces Receipt of Cultivation and Processing Licences for Robinsons Cannabis Facility

08/04/2019 - 13:00

VANCOUVER, British Columbia, April 08, 2019 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V - XLY) (" Auxly " or the " Company ") today announced that its wholly-owned subsidiary, Robinsons Cannabis Inc. (“ [...]